外文科技图书简介
当前位置:首页 > 检索结果 >文献详细内容

书名:Manganese in health and disease

责任者: Lucio G. Costa and Michael Aschner.  |  Aschner, Michael,

ISBN\ISSN:9781849739436 

出版时间:2015

出版社:The Royal Society of Chemistry,

分类号:医药、卫生


前言

Manganese (Mn) is the twelfth most abundant element in the Earth's crust and present in drinking water and in food. As an essential trace element, Mn is required for multiple biochemical and cellular reactions, and is a necessary component for numerous metallo-enzymes, such as Mn superoxide dismutase, arginase, phosphoenol-pyruvate decarboxylase, and glutamine synthase, to name a few.
Despite its essentiality, exposures to high levels of Mn from occupational, iatrogenic, medical, and environmental exposures may contribute to human morbidity. Excessive Mn accumulation in the brain, primarily in basal ganglia, may cause clinical signs and morphological lesions analogous to those seen in Parkinson's disease (PD), Other tissues may be affected as well.
Mn intoxication cases were originally described over two centuries ago. Manganism, resulting from exposure to exceedingly high levels of this metal, was originally described by James Couper (1837), providing insight into the adverse neurological effects in five Scottish men employed in grinding Mn dioxide ore. As Mn began to be used more widely in the steel alloy industry, more cases were recognized, with stronger epidemiological evidence implicating Mn in a number of neurological diseases. Contemporary exposures to Mn at levels described by Couper are rare, yet concerns about the health effects of Mn remain, given its abundant occurrence and the potential exposures throughout various life-stages.
This book, to our knowledge, is the first multidisciplinary scientific endeavor to address the health effects of Mn. It aims to provide state-of-the-art information and deepen the understanding of Mn's adverse health effects. It commences with a description on various pathways for Mn absorption (lung, gastrointestinal tract, olfactory pathway), followed by its nutritional needs, toxicokinetics and toxicodynamics. A large section of the book is devoted to its adverse effects, emphasizing cellular and molecular mechanisms of toxicity in a host of tissues and organs, particularly the nervous system, with emphasis on sensitivity to Mn at various life-stages. We conclude with a list of research needs that will further improve our understanding of the role of Mn both in health and disease.
We called upon internationally recognized experts on Mn to address and facilitate the understanding of its role in health and disease, making a valiant attempt to provide as broad and multidisciplinary approach as possible. Our goal was to assemble a series of chapters that advance the latest developments and scientific breakthroughs in this fast-paced research area, and to provide information that should be of interest to risk assessors, neurobiologists, and neurotoxicologists, as well as metal and trace element biologists. We are hopeful that the book offers the reader appreciation and renewed sense on contemporary issues in Mn research. We are indebted to the authors for their contributions and hope that, as a reader, whether you are a novice or a seasoned Mn researcher, the knowledge amassed herein will stimulate and transform your novel ideas into better understanding on the role of this unique metal in health and disease. Michael Aschner Lucio G. Costa

查看更多

目录

Chapter 1 Manganese Transport, Trafficking and Function in Invertebrates 1

      1.1 Introduction 1

      1.2 Function of Manganese in Biological Systems 2

      1.2.1 Manganese Metalloenzymes 2

      1.2.2 Non-Protein Manganese Antioxidants 2

      1.2.3 Manganese and Bacterial Virulence 4

      1.3 Manganese Transport in Bacteria 4

      1.3.1 Bacterial Manganese Uptake Systems 4

      1.3.2 Bacterial Manganese Efflux 8

      1.3.3 Regulation of Bacterial Manganese Transport 8

      1.4 Manganese Transport in Yeast 10

      1.4.1 Yeast High Affinity Manganese Uptake, Smf1p and Smf2p 10

      1.4.2 Manganese and Phosphate Coupled Uptake in Yeast, Pho84p 12

      1.4.3 Intracellular Manganese Distribution in Yeast 13

      1.4.4 Regulation of Yeast Manganese Transporters 15

      1.5 Manganese Transport in the nematode Caenorhabditis elegans 19

      1.5.1 Nramp Manganese Transporters in C. elegans 19

      1.5.2 Regulation of C. elegans Nramp Transporters by Manganese 20

      1.5.3 Intracellular Manganese Transporters in C. elegans 20

      1.6 Conclusions 21

      References 21

Chapter 2 Nutritional Requirements for Manganese 34

      2.1 Introduction 34

      2.2 Food Sources 35

      2.3 Absorption, Transport and Excretion 36

      2.4 Approaches to Assessing Mn Requirements 36

      2.4.1 Metabolic Balance 37

      2.4.2 Blood Levels of Mn 42

      2.4.3 Other Biomarkers 43

      2.4.4 Extrapolation to Usual Diet Intake 44

      2.5 Deficiencies 45

      2.6 Nutritional Recommendations for Mn 50

      2.6.1 Life Stage and Gender 50

      2.6.2 Infants 51

      2.6.3 Children and Adolescents 52

      2.6.4 Pregnancy 53

      2.6.5 Lactation 54

      2.6.6 International Variability of Requirements and Dietary Levels for Mn 55

      2.7 Influence of Bioavailability 56

      2.7.1 Fiber and Phytate 57

      2.7.2 Mineral Interactions 58

      2.7.3 Fat and Protein 61

      2.7.4 Polyphenolic Compounds 61

      2.8 Toxicity 61

      2.8.1 Parenteral Nutrition 62

      2.9 Conclusions 63

      References 64

Manganese: Toxicokinetics and Toxicodynamics

Chapter 3 Manganese Superoxide Dismutase 79

      3.1 Introduction 79

      3.2 Manganese Incorporation into SOD2 82

      3.3 Manganese Superoxide Dismutase is Essential for Life 82

      3.4 Post-Translational Modification of MnSOD 85

      3.4.1 Nitration of MnSOD Compromises Mitochondrial Function in Various Disease States 85

      3.4.2 Phosphorylation of MnSOD can Enhance Activity and Stability 88

      3.4.3 Acetylation of MnSOD Reduces Enzymatic Activity 88

      3.5 MnSOD and Redox Signaling 89

      3.6 Transcriptional Regulation of MnSOD Expression 92

      3.7 MnSOD and Disease 95

      3.7.1 Cancer 95

      3.7.2 Cardiovascular Disease 97

      3.7.3 Neurodegenerative Disorders 98

      3.7.4 MnSOD Polymorphisms and Disease 99

      3.8 Future Directions 100

      Abbreviation List 101

      References 102

Chapter 4 Olfactory Transport of Manganese: Implications for Neurotoxicity 119

      4.1 Introduction 119

      4.2 Anatomical Features of the Olfactory System 120

      4.3 Scientific Evidence in Support of Olfactory Transport of Manganese 121

      4.3.1 Manganese Transport Kinetics 124

      4.4 Manganese-Enhanced Magnetic Resonance Imaging (MEMRI) of the Olfactory System 125

      4.5 Toxicological Significance of Olfactory Transport of Manganese 125

      4.5.1 Olfactory System Pathology 126

      4.5.2 Biochemical Effects 126

      4.5.3 Olfactory Function 127

      4.5.4 Species Differences 127

      4.6 Conclusions 127

      References 128

Chapter 5 Manganese Transport Across the Pulmonary Epithelium 133

      5.1 The Air-Blood Barrier 133

      5.1.1 Microanatomy of the Lungs 133

      5.1.2 Lung Manganese Exposures 134

      5.2 Overview of Manganese Transport 135

      5.2.1 Divalent Metal Transporter-1 (Slc11a2) 135

      5.2.2 Ferroportin (Slc40a1) 136

      5.2.3 Transferrin/Transferrin Receptor (CD71) 137

      5.2.4 Other Manganese Transporters: Non-Selective Ion Channels 137

      5.2.5 Hypothetical Model for Pulmonary Manganese Transport 138

      5.3 Interplay Between Manganese and Iron Status 138

      5.3.1 Pulmonary Manganese Uptake and Iron Deficiency 140

      5.3.2 Iron Overload and Lung Manganese Absorption 142

      5.3.3 Roles for Tf and the Tf Receptor in the Lungs 142

      5.4 Non-Selective Ion Channels 143

      5.5 Toxic Effects of Manganese on Lung Epithelial Cells 144

      5.6 Infection and Manganese in the Lungs 145

      5.7 Future Directions 146

      Acknowledgements 148

      References 148

Chapter 6 Are There Distinguishable Roles for the Different Oxidation States of Manganese in Manganese Toxicity? 158

      6.1 Introduction 158

      6.2 A Brief Review of the Inorganic Chemistry of Mn~2+ and Mn~3+ 159

      6.3 Current Physical Techniques Useful in Mn Speciation 160

      6.3.1 UV-Visible Spectroscopy 160

      6.3.2 XANES Spectroscopy 161

      6.3.3 Electron Paramagnetic Resonance Spectroscopy (EPR) 163

      6.4 Studies Most Relevant to Mn Speciation 164

      6.5 Studies of Biological Effects of Exposure to Mn~2+ or Mn~3+ Complexes 166

      6.6 Is Mn~2+ Oxidized to Mn~3+ within Cells or Mitochondria? 170

      6.7 Transport of Mn~3+ via the Transferrin Mechanism 171

      6.8 The Toxicologically Important Steps of a Mn~2+-Inhibited Process 172

      6.9 Effects of Exposure to Nanoparticles Containing a Range of Mn Oxidation States 173

      6.10 Conclusions 174

      Acknowledgements 176

      References 176

Chapter 7 Effect of Manganese on Signaling Pathways 182

      7.1 Introduction 182

      7.2 Manganese may Alter Cell Signaling in the Striatum 183

      7.3 Manganese Modulation of Tyrosine Hydroxylase Activity 187

      7.4 Alteration in MAPK and AKT Signaling Induced by Manganese 188

      7.5 Manganese Action on GSK-3β and the Canonical Wnt/p-Catenin Pathway 191

      7.6 Final Considerations 192

      References 192

Chapter 8 Manganese and Oxidative Stress 199

      8.1 Introduction 199

      8.2 Mechanisms Mediating Mn-Induced Oxidative Stress and Toxicity 201

      8.2.1 Mn and Mitochondria 201

      8.2.2 Manganese and Dopamine Oxidation 204

      8.2.3 Manganese and Antioxidant Homeostasis 205

      8.2.4 Manganese and Protein Aggregates 205

      8.3 Antioxidant Approach against Manganism 207

      8.4 Concluding Remarks 209

      References 210

Chapter 9 Mutual Neurotoxic Mechanisms Controlling Manganism and Parkisonism 221

      9.1 Introduction 221

      9.2 Parkin 224

      9.3 DJ-1 226

      9.4 PINK1 229

      9.5 ATP13A2 230

      9.6 LRRK2 233

      9.7 α-Synuclein 234

      9.8 VPS35 236

      9.9 Others 237

      9.10 Conclusion 238

      References 239

Chapter 10 Mechanism of Manganese-Induced Impairment of Astrocytic Glutamate Transporters 258

      10.1 Introduction 258

      10.2 Mn Neurotoxicity 259

      10.2.1 Sources of Human Exposure to Mn and its Transport to the Central Nervous System 259

      10.2.2 Cellular Mechanisms of Mn Neurotoxicity 260

      10.3 Role of Astrocytes in Mn Neurotoxicity 262

      10.3.1 Mn-induced astrocyte swelling 262

      10.3.2 Glial Cell-derived Neuroinflammation in Mn Neurotoxicity 263

      10.3.3 Astrocytic Glutamate Transporters in Neurological Disorders 263

      10.3.4 Mn Reduces Expression and Function of Astrocytic Glutamate Transporters 264

      10.4 Mechanism of Mn-induced Impairment of Astrocytic Glutamate Transporters 264

      10.4.1 Mn-activated Signaling Pathways in Astrocytes 264

      10.4.2 Mn-induced Transcriptional Regulation of Glutamate Transporter GLT-1: Role of Yin Yang 1 265

      10.5 Summary 268

      Acknowledgements 268

      References 268

Chapter 11 Impairment of Glutamine/Glutamate-γ-aminobutyric Acid Cycle in Manganese Toxicity in the Central Nervous System 279

      11.1 Glutamine Content and Regional Distribution and its Role in the Central Nervous System 279

      11.2 Glutamine Transporting Systems in General 280

      11.3 Glutamate: Role in Central Nervous System and Transporters 281

      11.4 The Glutamine/Glutamate-γ-Aminobutyric Acid 283

      11.5 Manganese 284

      11.5.1 Essentiality and Toxicity 284

      11.5.2 Transporting System 284

      11.5.3 Manganese Effects on Astrocytes Function and Astrocyte-Neuronal Integrity 285

      11.5.4 Manganese Involvement in PKC5 Signalling 286

      11.6 Manganese and GGC 287

      11.6.1 Manganese and Glutamate Transporting System 287

      11.6.2 Manganese and Glutamine Turnover 288

      11.6.3 Manganese Involvement in SNAT3 Expression and Function 289

      11.7 Summary 290

      References 291

Chapter 12 Manganese and Neuroinflammation 297

      12.1 Introduction 297

      12.2 Astrocytes 298

      12.2.1 Description and Distribution of Astrocytes 298

      12.2.2 Functional Roles of Astrocytes 298

      12.3 Microglia 300

      12.3.1 Description and Distribution of Microglia 300

      12.3.2 Functional Roles of Microglia 301

      12.4 Neuroinflammation 301

      12.4.1 Overview of Neuroinflammation in the CNS 301

      12.4.2 Role of Astrocytes in Neuroinflammation 303

      12.4.3 Role of Microglia in Neuroinflammation 303

      12.4.4 NF-κB Signaling in Neuroinflammatory Injury from Manganese 304

      12.5 Neuroinflammation in Diseases of the CNS 305

      12.5.1 Seizure 305

      12.5.2 Parkinson's Disease 306

      12.5.3 Manganism 308

      12.6 Conclusion 313

      References 313

Chapter 13 Modeling Manganese Kinetics for Human Health Risk Assessment 322

      13.1 Introduction 322

      13.2 Key Findings from Mn Pharmacokinetic Studies 323

      13.3 Pharmacokinetic Modeling of Mn 328

      13.3.1 Initial Development 328

      13.3.2 Mn PBPK Models 329

      13.3.3 Inter-species Extrapolation to Non-human Primates 334

      13.3.4 Development of Human PBPK Models for Mn 336

      13.3.5 Life Stage Extrapolation 338

      13.4 Application of PBPK Models in Human Health Risk Assessment 343

      13.5 Suggested Research 345

      Acknowledgements 346

      References 346

Chapter 14 Significance and Usefulness of Biomarkers of Exposure to Manganese 355

      14.1 Introduction 355

      14.2 Biological Matrices and Reference Values 356

      14.2.1 Mn in Blood 356

      14.2.2 Mn in Urine 357

      14.2.3 Mn in Hair and Nail 357

      14.2.4 Mn in Brain 358

      14.2.5 Reference Values 359

      14.3 Occupationally Exposed Subjects 366

      14.3.1 External-Internal Exposure Relationship: Ambient Air-Biomarker 366

      14.3.2 Internal Exposure - Effect Relationship 383

      14.4 Non-Occupational Exposure 384

      14.4.1 Environmental Exposure 384

      14.4.2 Other Mn Exposures 385

      14.5 Conclusion 386

      References 387

Manganese: Health Effects

Chapter 15 Manganese and Parenteral Nutrition 405

      15.1 Parenteral Nutrition and Manganese [Mn] Supplementation 405

      15.2 Existing Guidelines for Parenteral Manganese Supplementation 406

      15.2.1 Adult Guidelines 406

      15.2.2 Pediatric Guidelines 407

      15.3 Risk Factors for Manganese Excess and Toxiciry 410

      15.3.1 Disease States 410

      15.3.2 Nutritional Iron Status 411

      C\15.4 Consequences of Excessive Parenteral Mn 411

      15.4.1 Adults: Manganism and other Neuropsychiatric Disorders 411

      15.4.2 Infants and Children: Cognition and Neurodevelopment 412

      15.5 Detection of Manganese Body Burden 414

      15.5.1 Mn Measurements in Blood 414

      15.5.2 Magnetic Resonance Imaging (MRI) 415

      15.6 Future Directions for Optimizing Mn in Parenteral Nutrition 416

      15.6.1 Knowledge Gaps and Research Priorities 416

      15.6.2 Recommendations for Clinical Practice Modifications 416

      Acknowledgements 417

      References 417

Chapter 16 Developmental Effects of Manganese 426

      16.1 Introduction 426

      16.2 Manganese Deficiency and Development 427

      16.3 Manganese Toxicity and Development 427

      16.3.1 Brain Development 428

      16.3.2 Birth Outcomes 430

      16.3.3 Onset of Puberty 431

      16.4 Conclusions 432

      References 433

Chapter 17 The Effects of Manganese on Female Pubertal Development 437

      17.1 Introduction 437

      17.2 Critical Events Associated with the Normal Onset of Female Puberty 438

      17.3 Acute Effects of Mn on Puberty-Related Hormones: A Hypothalamic Site of Action 439

      17.4 Chronic Effects of Mn on Puberty-Related Hormones and the Timing of Puberty 440

      17.5 Downstream Mechanism(s) of Mn Action on GnRH Release 442

      17.6 Effect of Mn on GnRH Gene Expression 443

      17.7 Upstream Mechanisms of Mn Action in the Control of GnRH Neuronal Activity 447

      17.7.1 Mn Action on Kiss-1 Gene Expression 447

      17.7.2 A Potential Role for Divalent Metal Transporter-1 449

      17.8 Low Level Mn Exposure and Precocious Puberty 450

      17.9 Conclusions 451

      Acknowledgements 452

      References 453

Chapter 18 A Decade of Studies on Manganese Neurotoxicity in Non-Human Primates: Novel Findings and Future Directions 459

      18.1 The Early Studies on Manganese Neurotoxicity in Non-Human Primates 459

      18.2 Early Behavioral and Neuroimaging Findings 461

      18.2.1 Behavioral Findings 461

      18.2.2 Positron Emission Tomography Findings 462

      18.2.3 Magnetic Resonance Spectroscopy and T1-Weighted Magnetic Resonance Imaging Findings 463

      18.3 Chronic Mn Exposure Impairs Dopamine Neuron Function in the Striatum and Produces Extensive Degeneration in the Frontal Cortex 464

      18.3.1 Effects of Chronic Mn Exposure on Dopaminergic Neuron Terminals in the Striatum Measured by PET and Confirmation by Ex Vivo Methods 464

      18.3.2 Effects of Chronic Mn Exposure on the Glutamatergic and GABAergic Systems 466

      18.3.3 The Frontal Cortex in Mn-Exposed Non-Human Primates: Alzheimer's Disease-like Pathology and Neurodegeneration 467

      18.4 Behavioral Studies Reveal Significant Impairment in Working Memory and Visuospatial Paired Associative Learning in Mn-Exposed Non-Human Primates 469

      18.5 Novel Findings and Future Directions 470

      Acknowledgements 471

      Dedication 472

      References 472

Chapter 19 Imaging Modalities for Manganese Toxicity 477

      19.1 Introduction 477

      19.2 Magnetic Resonance Imaging 478

      19.2.1 Basics of MRI 478

      19.2.2 Manganese as MRI Contrast Agent 479

      19.2.3 Morphological Changes Assessed by MRI 485

      19.2.4 Magnetic Resonance Spectroscopy 486

      19.2.5 Diffusion Weighted Imaging 489

      19.2.6 Functional MRI 490

      19.3 PET and SPECT Imaging 491

      19.3.1 PET Studies in Non-Human Primates 492

      19.3.2 PET Studies in Human Subjects 493

      19.3.3 SPECT Studies 496

      19.4 X-Ray Fluorescence 497

      19.5 Conclusions 500

      Acknowledgements 501

      References 501

Chapter 20 Epidemiological Studies of Parkinsonism in Welders 513

      20.1 Parkinsonism: Clinical, Pathological, and Epidemiological Features 513

      20.2 Manganese and Parkinsonism: Historical Background 514

      20.3 Epidemiological Studies of PS/PD among Welders 515

      20.4 Discussion 515

      References 520

Chapter 21 Cognitive Effects of Manganese in Children and Adults 524

      21.1 Introduction 524

      21.2 Cognitive Effects in Children 525

      21.2.1 Reduction of IQ 528

      21.2.2 Executive Functions 528

      21.2.3 Memory 529

      21.2.4 Academic Achievement 529

      21.2.5 Mental Development 530

      21.3 Cognitive Effects in Adults 530

      21.3.1 Occupational Studies 530

      21.3.2 Environmental Studies 532

      21.4 Conclusions 533

      References 533

Chapter 22 Manganese and Huntington Disease 540

      22.1 Huntington Disease Pathobiology and Environmental Influence 540

      22.2 A History of HD and Metal Ions 541

      22.2.1 Manganese and HD 542

      22.2.2 Iron Homeostasis and HD 543

      22.2.3 Copper and HD 545

      22.3 Manganese Essentiality and Toxicity in HD Related Phenotypes 545

      22.3.1 Regulation of Amines and Nitric Oxide 546

      22.3.2 Glutamate Exci Co toxicity 547

      22.3.3 Mitochondrial Dysfunction: Oxidative Stress and Energetics 551

      22.3.4 IGP/PI3K/AKT Signaling in HD and Manganese Exposure 554

      22.3.5 p53 Pathway 556

      22.4 Conclusions 558

      References 559

Chapter 23 Manganese and Prion Disease 574

      23.1 Introduction 574

      23.2 Prion Diseases 576

      23.2.1 Creutzfeldt-Jakob Disease (CJD) 576

      23.2.2 Kuru 577

      23.2.3 Gerstmann-Straussler-Scheinker Syndrome 578

      23.2.4 Fatal Familial Insomnia 578

      23.3 Prion Protein (PrP~c) 580

      23.3.1 Structure of PrP~c 580

      23.3.2 Physiological Function of Prion Protein 581

      23.4 Metals and Prion Diseases 583

      23.4.1 Manganese 583

      23.4.2 Manganese Binding to PrP~c 584

      23.4.3 Role of Manganese in the Pathogenesis of Prion Disease 585

      23.4.4 Role of Manganese in the Physiological Function and Expression of PrP~c 588

      23.4.5 Role of other Metals in Prion Disease 589

      23.5 Conclusions 590

      Acknowledgements 590

      References 590

Chapter 24 DNA Damage Induced by Manganese 604

      24.1 Genotoxic Lesions Induced by Manganese 604

      24.1.1 Damage Induced by Manganese at the Chromosomal Level 604

      24.1.2 Damage Induced by Manganese at the DNA Level 608

      24.1.3 Mutations Induced by Manganese 609

      24.2 Sources of the Genotoxic Potential of Manganese 610

      24.3 Consequences of DNA Damage Induced by Manganese 613

      24.4 Conclusions 614

      References 614

Post-face 621

Subject Index 624

查看PDF
查看更多

馆藏单位

中国医科院医学信息研究所